Clinical Trial Update: A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C [Phase 1, Phase 2]

View source ↗

Summary

An early-phase trial evaluating SC Hanferon in combination with Ribavirin for treatment-naïve Genotype 1 Hepatitis C has completed a Phase 1b/2a study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Hanferon
• Ribavirin (ribavirin)

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Chronic Hepatitis C Infection, Genotype 1 | Phase 1, Phase 2 | Status: COMPLETED